2024 Corporate Partners

Thank you to our ISCT 2024 Corporate Partners

BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, we specialize in control and disease state samples including human and animal tissues or preparations, cell and gene therapy products, blood, and other biofluids, as well as ADME contract research services from standalone bioanalytical support through tiered in vitro studies with submission-ready reports to customized consulting. By combining our technical expertise, exceptional customer service, and unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

Visit Website

MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The Company's technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. Our Flow Electroporation® technology and next-generation ExPERT™ platform enable our partners to accelerate, streamline, and improve the drug development process from the early stages of research to commercialization. Founded in 1998, MaxCyte is headquartered in Gaithersburg, Maryland, U.S.

Visit Website

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy.

Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing.

Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training.

Today, Miltenyi Biotec has more than 4,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Visit Website

ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf.

Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry.

Our platform includes GRex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.

Visit Website

Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results.

By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to accelerate your discoveries. 

Our goal is to bring a unique perspective to the flow cytometry tools required for in-depth single cell isolation and analysis.

With our core expertise in automation and software development we hope to enable discovery research across immunology, oncology, cell biology and microbiology.

Visit Website

Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as regenerative medicine, immunotherapy, and disease research.

Whether you're culturing and editing hematopoietic stem and progenitor cells, differentiating pluripotent stem cells, or activating and expanding immune cells, we have the specialized cell isolation products, high-performance cell culture media, and accessory tools for your research. 

By increasing the accessibility of innovative techniques like gene editing and organoid cultures, we’re helping scientists accelerate the pace of discovery—so they can get therapies to patients faster.

Researchers in need of high-compliance products can also obtain guidance and customized support through our Services for Cell Therapy Program on how to qualify our products for use as raw/ancillary materials.

Visit Website

A global leader in in-vitro diagnostics for over 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide.

The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety.

At bioMérieux, we are proud to have a long history in the field of industrial microbiology. Cutting-edge cell and gene therapy products demand state-of-the-art quality control.

With a comprehensive portfolio of rapid microbiology testing solutions, bioMérieux can help streamline workflows, boost efficiency, prevent compliance issues and ensure patient safety.

Visit Website

PBS Biotech, Inc. offers unique single-use bioreactors and contract process development services for the global cell therapy market.

Our family of Vertical-Wheel bioreactors provides optimal and scalable hydrodynamic conditions for human cells including induced pluripotent stem cells, mesenchymal stem cells, T-cells, natural killer cells and other cell types.

Our Bioprocess R&D team possesses unparalleled knowledge regarding cell culture process development for a variety of cell types and applications.

PBS Biotech is committed to providing scalable solutions for all stages of cell therapy manufacturing, from R&D to clinical studies and ultimately commercial production.

Visit Website

Terumo Blood and Cell Technologies is a medical technology company.

Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions.

Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. 

Visit Website

As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support need to accelerate the pace of cell and gene therapy development.

We understand the complexity of this rapidly-evolving industry and have made significant investments in cGMP raw material manufacturing and drug product manufacturing capabilities to provide innovative workflow solutions.

Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing.

Through our Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab services, Patheon, and Gibco brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.

Visit Website

Since 2006, Akron’s mission has been to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies.

Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies.

Akron’s ancillary material product lines are ISO 13485-certified and its 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards.

Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through commercialization.

Visit Website

BCA centers generate >$3B in revenue annually managing >50% of the country’s supply of blood and blood components from >500 facilities owned by ~65 centers in 43 states supplying biomaterials from >3.5 million annual donors to thousands of hospitals.

BCA additionally represents access to 7 cord blood banks and 16 IRL testing facilities in 13 states. BCA itself manages >$1B in transactions generated through purchasing/selling contracts it has negotiated and manages on behalf of its members.

Specifically on the advanced therapies side, in 2021 BCA sites performed >10,000 cell therapy (autologous & healthy donor) collections + >20,000 therapeutic apheresis procedures on ~380 Optia devices at >50 locations. Many of these sites have or have already planned in the budget to incorporate or expand cryopreservation capabilities.

Visit Website

BioBridge Global, a San Antonio-based 501(c)(3) nonprofit, integrates donor-to-patient services to enable the future of biotherapeutic solutions, including blood, tissue and advanced therapies.

Through its subsidiaries – South Texas Blood & Tissue, QualTex Laboratories and GenCure – BioBridge Global provides products and services in blood resource management, cellular therapy manufacturing, donated umbilical cord blood and human tissue, as well as testing of blood, plasma, tissue and cellular products for clients in the United States and international markets. It supports the development of advanced therapies by providing access to starting materials, testing services, biomanufacturing and clinical trials support.

BioBridge Global is committed to saving and enhancing lives through the healing power of human cells and tissue.

Visit Website

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services.

Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems® high-capacity cryogenic storage freezers, SciSafe biologic materials storage, Stirling Ultracold ULT freezers, and Sexton Biotechnologies cell processing tools.

For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com and www.sextonbio.com and follow BioLife on Twitter.

Visit Website

Bio-ReCell is a cell therapy research and development company at the forefront of biomedical advancement.

Our team of seasoned experts in the field alongside young researchers, has led to the creation of the world's first closed and automated Bio-ReCell System, redefining cell separation and isolation standards within the industry.

Our revolutionary technology relies on a proprietary antibody-based approach, completely eliminating the need for magnetic particles. This innovation ensures that the resulting cell eluates are entirely devoid of contaminants, including residual antibodies, chemicals, and any other particles.

We maintain rigorous standards of sterility and bio compatibility, employing closed-loop cartridges tailored to specific cell types, which complete the isolation process in under 30 minutes. Scalability is a fundamental feature of our technology, accommodating the full spectrum of requirements, from single-patient applications to large-scale Good Manufacturing Practice (GMP) manufacturing processes.

Our versatile portfolio of cartridges targets various therapeutic objectives, primarily focusing on T-cells for advanced CAR-T therapies. Our product range includes also a system for cell activation, based on our proprietary technology. Bio-ReCell actively seeks strategic partnerships in both, commercial and research sectors, with a strong commitment to advancing cell and gene manufacturing and exploring novel clinical applications through collaborative clinical trials.

Visit Website

Cryoport Systems is the market leader in integrated temperature-controlled supply chain solutions for critical, irreplaceable products and materials in the life sciences industry.

We are already trusted to support over 650 active clinical trials and leading commercial products worldwide - delivering unparalleled supply chain services for products, therapies and treatments requiring specialized temperature-controlled management. And, as the life sciences constantly evolve and advance, so do we.

Visit Website

908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications.

The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets.

The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.

Visit Website

With over 50 years of focus in the development and optimization of cell culture media, FUJIFILM Irvine Scientific is driven to develop scalable, innovative media for the life science, biotech, and biopharmaceutical fields.

Our expertise and understanding of the challenges within integrated end-to-end workflow solutions, paired with our legendary customer service and technical support, enables us to partner with customers to create complete, optimized media solutions, ready for scale-up, that help bring therapies to market faster.

Visit Website

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases.

We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence.

Our Cell & Gene offering spans across development and manufacturing services, products, solutions, testing and automation platforms as well as tools and technologies to enable you to develop, de-risk and industrialize your therapy, from basic research to commercialization.

Visit Website

A nonprofit organization committed to clinical practice, education, and research, providing whole-person care to everyone who needs healing.

The needs of the patient come first. 

Visit Website

Ori is a London and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies.

Ori has developed a proprietary, fullstack manufacturing platform that closes, automates and standardizes CGTmanufacturing, allowing therapeutics developers to develop and bring their products to market at commercial scale.

The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics.

Visit Website

AMSBIO is contributing to the acceleration of discovery through the provision of cutting-edge life science products and services for R&D. We provide solutions for studying cell motility, migration, invasion and proliferation.

We also offer solutions for organoid and spheroid culture, regenerative medicine and stem cell research. For PDX applications and organoid, spheroid, and pluripotent stem cell culture, AMSBIO offers two innovative hydrogel matrix products.

Extragel serves as a like-for-like replacement for Matrigel™, Geltrex™, and Cultrex™ Basement Membrane Extract (BME). On the other hand, MatriMix is a fully-defined alternative to current options, offering enhanced performance in various applications.

Visit Website

ASEPTIC TECHNOLOGIES develops, manufactures and markets innovative aseptic solution for the BioPharmaceutical industry.

Its equipment and devices are designed to provide safer & easier operations for aseptic fill and finish, the best-known being the AT-Closed Vial® technology.

The AT-Closed Vial® is manufactured in ISO 5 clean room with the stopper secured in place and gamma sterilized. Vial size ranges from 1 to 50ml. The filling of these ready-to-use vials is performed by a special needle piercing the stopper and dispensing the drug product. The stopper is then immediately resealed by a laser and a cap is snap-fitted on it. Various equipment offer an easy scale-up from manual to fully automated operation.

The benefits of the technology are: better sterility assurance, reduced investments, increased safety during whole supply chain, strong operating cost reduction.

The AT-Closed Vial® technology is widely used in the Cell and Gene Therapies as it offers uncompromised container closure integrity even during storage at cryogenic temperature.

Visit Website

AventaCell BioMedical Corp. ("AventaCell") is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration.

Helios Bioscience is AventaCell's product family brand for their products to be used in cell culture and tissue regeneration. AventaCell technologies used in the Helios Bioscience line offer new human-derived solutions for use in translational research of cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production.

The demand for safe, efficient and cost-effective cell expansion and production is rapidly increasing with the growth in cell therapy and regenerative medicine research and clinical development.

Helios Bioscience products are designed to support expansion and production of a broad range of cells including mesenchymal stem cells and multiple immunocell lines.

AventaCell is committed to providing animal serum-free products to accelerate the research, development and commercialization of safe and efficacious cell and tissue-based therapeutics.

Visit Website

For over 30 years, Bionique Testing Laboratories continues to be a trusted partner and global leader in Mycoplasma Testing Services for the life science industry.

We offer the full range of testing services from relevant compendia (USP <63> Mycoplasma Test) to a GMP compliant Real-Time PCR assay to support the development and clinical manufacturing of cell & gene therapies.

From discovery to commercialization, our capabilities extend to method development and validation of rapid microbial methods to meet global regulatory requirements. Bionique delivers testing services that meet the highest quality standards and offers the fastest turnaround times in the industry.

Visit Website

BioLamina offers an expansive portfolio of human recombinant laminin proteins for a variety of applications. With our cell therapy grade products, we can support scientists throughout their cell therapy development process – from concept to commercialized therapy.

Our Biolaminin® substrates are defined, full-length laminin cell culture matrices that can be used for a variety of applications, like the expansion of human pluripotent stem cells and differentiation and maintenance of different specialized cell types, such as hepatocytes, cardiomyocytes, and neural cells.

The biologically relevant cell-matrix interaction gives more consistent cellular responses, more standardized experiments, improve the differentiation potential, and keep adult cells mature for a significantly longer time in culture than has previously been feasible.

Our Biosilk® 521 product is a new 3D biomaterial that combines the biological instructive cues from ECM laminins with the mechanical and topological support from silk, allowing engineered, controllable, and tunable organoids.

BioLamina is a Swedish biotechnology company with a global presence and our laminin technology has been scientifically validated in many high impact journals.

Visit Website

The market’s most experienced provider of apheresis derived products, the BioSharing Network is a partnership between eight US blood centers.

The network has over two million donors and has decades of experience recruiting donors and performing apheresis procedures.

Our network provides GMP (mobilized & non-mobilized) leukopacks, bone marrow, cord blood and perinatal tissue, as well as providing support services including flowcytometry, cryopreservation and prodigy-based manufacturing.

With multiple donor rooms, clean rooms for manufacturing, and strong logistics teams, we are a the most reliable provider in the market.

Visit Website

BioSpring is a leading industry expert in oligonucleotide science and technology, specializing in high-quality cGMP manufacturing and analytics for commercial programs and clinical phases I-III, in addition to preclinical material supply and diagnostic manufacturing.

We are a privately owned company of over 600 employees committed to providing expert support through all phases and regulatory filings, including highly flexible and customizable solutions to accelerate therapeutic programs through the entire drug development lifecycle.

Headquartered in the center of Europe, in Frankfurt, Germany, we are an international company with a subsidiary in the United States and a local presence in Japan. Our global clients can rely on our quality and expertise, guided by our passion for innovation and more than 26 years of experience.

Our aim is a highly collaborative partnership to unleash the full potential of our clients’ technology – making great strides and breakthroughs possible. We are driven by our desire for a healthier world. Restoring hope in patients living with debilitating diseases is our daily motivation to progress novel nucleic acid-based therapies to their commercial promise.

Visit Website

Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services.

Science is our passion; it drives us to collaborate, develop, and manufacture award-winning tools that help researchers achieve reproducible and consistent results.

Whether you are at the cutting edge of academic research, translating basic discoveries to therapeutic leads, or at a facility that requires the highest level of diagnostic testing, our innovative products and services provide the solutions you need to achieve success.

Visit Website

CARR Biosystems UniFuge single-use Centrifuge systems provide separation processes with reliably high cell viability and separation efficiency, improving yield for manufacturers of cell therapies, gene therapies, recombinant therapeutics, vaccines and cultured meat products.

Today, top biopharma companies manufacture licensed products using our fully closed, automated systems that are optimized to recover whole cells or supernatant.

To learn more about CARR Biosystems and our scalable single-use separation systems.

Visit Website

CellFE is an innovative microfluidics company whose mission is to make cell therapies accessible for all by streamlining the development process.

The company has developed a novel cell engineering platform with highest cell health and payload delivery with streamlined and automated workflows.

Benefits include increased cell yield and reduced expansion times that translate to shorter vein-to-vein times and lower manufacturing costs.

CellFE is committed to its partners’ success through its close collaborations to solve challenges facing the delivery of advanced cell therapies.

Visit Website

c-LEcta is a global biotechnology company specializing in the development, production and distribution of enzyme products.

The company uses world-class enzyme engineering and production technologies to provide its partners in the food and pharmaceutical industries with superior biotechnological solutions for innovative industrial applications. c-LEcta is part of the Kerry Group.

Visit Website

GenScript is the world’s leading technology and service provider of life science R&D and manufacture.

 Built upon its solid gene synthesis technology, GenScript Biotech is divided into four major platforms including the life science service and product platform, the biologics contract development and manufacturing organization (CDMO) platform, the industrial synthetic products platform, and the integrated global cell therapy platform.

With an unwavering commitment to advancing these fields, we empower researchers and biopharmaceutical companies to drive groundbreaking discoveries and develop life-changing therapies. Our expertise in Non-viral Cell Engineering Platforms (CRISPR/Cas Plasmids, sgRNA, Cell Lines, HDR templates, IVT mRNA), Viral Cell Engineering Platforms (GMP/CMC Plasmid, Viral Vector Packaging), and Antibody & Peptide Services, positions us at the forefront of innovation.

We provide tailored solutions, ensuring that our partners have the tools and support needed to accelerate the development of cell and gene therapies. GenScript's dedication to quality and compliance with stringent regulatory standards ensures the safety and effectiveness of these therapies, ultimately offering hope to patients grappling with previously incurable conditions.

As pioneers in this dynamic field, we invite you to join us on this extraordinary journey to unlock the potential of gene and cell therapy, transforming the future of healthcare for the better.

Visit Website

Halo Labs knows aggregates and particles. Aura® can count and characterize subvisible particles and tell you if they are aggregated drug product, excipients, or external contaminants.

A simple, plate-based approach enables low-volume, high-throughput, fully automated particle imaging and analysis at any stage from developability assessment through quality control.

Visit Website

Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products.

In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.

The systematically structured portfolio of up-scalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production.

Visit Website

Mill Creek Life Sciences was the first company to commercially sell human platelet lysate (hPL). Born in a cGMP cell therapy lab, our human platelet lysates have been used to grow cells for thousands of patients globally in more than 50 Phase I, II, and III clinical trials for more than a decade.

Our hPL products are derived from human platelets and offer unparalleled cell growth in cellular therapy. Mill Creek Life Sciences is committed to discovering and applying innovative approaches to cellular therapy and patient care.

Our leading products are PLTGold® and PLTMax®, with gamma irradiated versions available. Initially developed for use with MSCs, our human platelet lysates have evolved into a platform technology that has been used with successful results with many other cell types and applications, including 2D and suspension cultures, as well as organoids. 

Additional cell types grown with our products include T cells, NK cells, tumor cells, endothelial cells, iPSCs, and more. Mill Creek Life Sciences was founded with a singular purpose in mind: to bring new solutions to accelerate cellular therapies for patients.

For us it is about quality, innovation and customer service. We work closely with our customers, helping fulfil their needs and supporting them through analyzing and troubleshooting specific applications when needed.

Visit Website

Distribution of molecular biology contamination control products for biopharma and research.

Visit Website

NanoEntek is a leading innovator in the field of life science research, providing state-of-the-art products and solutions to laboratories and researchers worldwide.

With a commitment to advancing scientific discovery, NanoEntek has established itself as a trusted name in the industry. 

Founded in 2000, NanoEntek has continuously pushed the boundaries of life science research. The company's mission is to empower scientists with innovative tools that enhance their ability to explore and understand biological systems.

Over the years, NanoEntek has achieved significant milestones, including the development of cutting-edge technologies that have revolutionized cell counting analysis, and imaging.

Visit Website

OrganaBio is a robust and reliable biotech solutions provider for cell therapy and immunotherapy developers.

OrganaBio has opened doors to a new Contract Technology Development and Manufacturing Organization (CTDMO) paradigm that involves a passionate commitment to ethically accelerating the deployment of cell therapies through making accessible critical resources that are essential for therapeutics development.

Visit Website

OriGen Biomedical® manufactures industry-preferred products for cell therapy.

Our products include the CryoStore Freezing Bag, PermaLife Cell Culture Bag, CryoPur DMSO Solutions, and compatible Accessory Sets.

Visit Website

PeptiGrowth Inc., a joint venture between Mitsubishi Corporation and PeptiDream Inc., is supporting the growth of regenerative medicine and cell therapy industry by offering a series of synthetic peptides that have equivalent functions to growth factors.

Our peptides are chemically synthesized, completely animal component-free, and can achieve highly consistent quality, excellent scalability, and reasonable cost.

PeptiGrowth has launched 6 products as of September 2023 – HGF, TGF-β1 inhibitor, BDNF, Noggin, and BMP 4 or 7 selective inhibitor peptides – and is planning to launch more products in iPSC and hematological fields including VEGF, Wnt3a, FGF2, PDGF-AA, and TPO peptides in the next 6 months.

Visit Website

Preserving Life For Tomorrow™ Protide Pharmaceuticals, Inc. is a fully integrated organization devoted to innovative solutions that support research and development in regenerative medicine, cancer biology, cell bioenergy, cancer immunology, translational medicine, epigenetics, and islet cell transplantation.

 With over 37 years of innovative products and services, and hundreds of clinical trials using our technology, we positively impact science through knowledge.

Inspired by the scientists, patients, and physicians we support, Protide continues as an entrepreneurial, science driven organization.

Visit Website

QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services.

Since 1995, it has rapidly expanded from a tiny bioanalysis shop to a full-service CRO with 1,200+ employees in the US, Europe, India and Asia.

Today, it offers expanded pharmaceutical contract R&D services with special expertise in Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, and Clinical Development.

Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers.

For more information, visit www.qps.com or email info@qps.com.

Visit Website

Saint-Gobain Life Sciences is an industry-leading provider of material science-based solutions for single-use fluid management, including TPE and silicone tubing, connection and flow control components, bioprocess and cell culture bags, filtration products, sensors, and over-molded technology, all available in customized assemblies that are produced in 20 manufacturing facilities located around the world.

Visit Website

Scinus Cell Expansion provides technologies and process development to enable and improve cell therapy and regenerative medicine.

Our main product is the SCINUS bioreactor NG, which is a closed bioreactor system for the controlled cultivation of cells, supporting R&D as well as GMP processes.

 Combined with either the single-use Adherent or Suspension Bag it provides a scalable system for large-fold expansion. The temperature-controlled hardware enclosure houses the Single-use Bags on a unique, volume-expandable, rocking platform that provides an optimally homogenized culture environment with minimal shear stresses.

Two different single use bioreactor bag can be used to cultivate adherent cells (e.g. human mesenchymal stromal cells), as well as suspension cells (e.g. T-cells, NK cells) to clinically relevant numbers. Both bags can be used with the same Scinus Cell Expansion system configuration.

For an illustrative animation, please check our website (www.scinus.com).

Visit Website

STEMSOFT offers a full electronic solution designed to document all phases of patient care and product manufacturing to help save you time; comply with quality and accreditation requirements; and easily access a complete dataset for analysis.

Visit Website

As a leading CRO specializing in virus and prion safety testing, ViruSure offers comprehensive biosafety solutions for CGT products and biopharmaceuticals.

Our GLP/GMP-certified in vitro and in vivo facilities ensure the highest quality standards, baked by a proven track record of reports accepted by regulatory authorities worldwide.

We provide expert guidance tailored to your specific CGT product, spanning a diverse range, including cell therapy, CAR T-cells, iPSCs, gene editing, exosomes, and tissue engineering.

Our service portfolio includes: SAFETY TESTING - Cell and virus characterization - In vitro/in vivo adventitious testing - RCL and RCA testing MOLECULAR BIOLOGY - Rapid mycoplasma testing by qPCR - qPCR for pathogenic viruses (human, bovine, porcine and more) - Viral titre determination by dPCR - Genetic stability by dPCR - Sanger sequencing NEXT GENERATION SEQUENCING - NGS for adventitious testing (virus, sterility, mycoplasma) - NGS for genetic characterization (sequence identity confirmation) IN VIVO TESTING - Tumorigenicity & oncogenicity studies - In vivo biodistribution studies tailored to CGT OTHER SERVICES - Long-term storage facility - Virus/prion clearance studies - TEM - Cell and virus banking

Visit Website